Jayarajan; Pradeep

Patent Applications and Registrations

Patent applications and USPTO patent grants for Jayarajan; Pradeep.The latest application filed is for "new uses of a 5-ht4 receptor agonist".

Company Profile

8.21.22

Jayarajan; Pradeep - Telangana IN
Jayarajan; Pradeep - Hyderabad IN
Jayarajan; Pradeep - Andhra Pradesh IN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Triple combination of pure 5-HT.sub.6 receptor antagonists, acetylcholinesterase inhibitors and NMDA receptor antagonist Grant 11,253,514 - Nirogi , et al. February 22, 2	2022-02-22
Heteroaryl compounds as muscarinic M1 receptor positive allosteric modulators Grant 11,234,979 - Nirogi , et al. February 1, 2	2022-02-01
New Uses Of A 5-ht4 Receptor Agonist App 20210386727 - NIROGI; Ramakrishna ; et al.	2021-12-16
New Uses Of A Pure 5-ht 6 Receptor Antagonist App 20210338661 - NIROGI; Ramakrishna ; et al.	2021-11-04
Combination of pure 5-HT6 receptor antagonists with NMDA receptor antagonist Grant 11,116,764 - Nirogi , et al. September 14, 2	2021-09-14
Method Of Treatment With Histamine-3 Receptor Inverse Agonist App 20210213026 - NIROGI; Ramakrishna ; et al.	2021-07-15
Muscarinic M1 receptor positive allosteric modulators Grant 11,040,026 - Nirogi , et al. June 22, 2	2021-06-22
Heteroaryl Compounds As Muscarinic M1 Receptor Positive Allosteric Modulators App 20200237761 - NIROGI; Ramakrishna ; et al.	2020-07-30
Combination of histamine-3 receptor inverse agonists with acetylcholinesterase inhibitors Grant 10,603,323 - Nirogi , et al.	2020-03-31
Muscarinic M1 Receptor Positive Allosteric Modulators App 20190343812 - NIROGI; Ramakrishna ; et al.	2019-11-14
Triple Combination Of Histamine-3 Receptor Inverse Agonists, Acetylcholinesterase Inhibitors And Nmda Receptor Antagonist App 20190336509 - NIROGI; Ramakrishna ; et al.	2019-11-07
Combination Of Pure 5-ht6 Receptor Antagonists With Nmda Receptor Antagonist App 20190175586 - NIROGI; Ramakrishna ; et al.	2019-06-13
Triple Combination Of Pure 5-ht6 Receptor Antagonists, Acetylcholinesterase Inhibitors And Nmda Receptor Antagonist App 20190160055 - NIROGI; Ramakrishna ; et al.	2019-05-30
Combination Of Histamine-3 Receptor Inverse Agonists With Acetylcholinesterase Inhibitors App 20190160075 - NIROGI; Ramakrishna ; et al.	2019-05-30
Combination Of Pure 5-ht6 Receptor Antagonists With Acetylcholinesterase Inhibitors App 20190125743 - NIROGI; Ramakrishna ; et al.	2019-05-02
Amide compounds as 5-HT4 receptor agonists Grant 9,957,257 - Nirogi , et al. May 1, 2	2018-05-01
Amide Compounds As 5-ht4 Receptor Agonists App 20180051011 - NIROGI; Ramakrishna ; et al.	2018-02-22
Heteroaryl compounds as 5-HT.sub.4 receptor ligands Grant 9,636,335 - Nirogi , et al. May 2, 2	2017-05-02
Heteroaryl Compounds As 5-ht4 Receptor Ligands App 20150283125 - NIROGI; Ramakrishna ; et al.	2015-10-08
Compounds as histamine H3 receptor ligands Grant 9,079,888 - Nirogi , et al. July 14, 2	2015-07-14
Heteroaryl compounds as 5-HT.sub.4 receptor ligands Grant 9,079,894 - Nirogi , et al. July 14, 2	2015-07-14
Heterocyclyl compounds as histamine H.sub.3 receptor ligands Grant 8,912,179 - Nirogi , et al. December 16, 2	2014-12-16
Heteroaryl Compounds As 5-ht4 Receptor Ligands App 20140187581 - Nirogi; Ramakrishna ; et al.	2014-07-03
Heterocyclyl Compounds As Histamine H3 Receptor Ligands App 20140148440 - Nirogi; Ramakrishna ; et al.	2014-05-29
Bicyclic compounds as .alpha..sub.4.beta..sub.2 nicotinic acetylcholine receptor ligands Grant 8,735,423 - Nirogi , et al. May 27, 2	2014-05-27
Novel Compounds As Histamine H3 Receptor Ligands App 20140135304 - Nirogi; Ramakrishna ; et al.	2014-05-15
.alpha..sub.4.beta..sub.2 neuronal nicotinic acetylcholine receptor ligands Grant 8,653,071 - Nirogi , et al. February 18, 2	2014-02-18
1,2-dihydro-2-oxoquinoline compounds as 5-HT.sub.4 receptor ligands Grant 8,598,204 - Nirogi , et al. December 3, 2	2013-12-03
Aryl sulfonamide amine compounds and their use as 5-HT6 ligands Grant 8,404,720 - Nirogi , et al. March 26, 2	2013-03-26
BICYCLIC COMPOUNDS AS alpha4 beta2 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS App 20130072518 - Nirogi; Ramakrishna ; et al.	2013-03-21
Alpha 4 Beta 2 NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS App 20120322808 - Nirogi; Ramakrishna ; et al.	2012-12-20
1,2-dihydro-2-oxoquinoline Compounds As 5-ht4 Receptor Ligands App 20120277216 - Nirogi; Ramakrishna ; et al.	2012-11-01
Aryl Sulfonamide Amine Compounds And Their Use As 5-ht6 Ligands App 20120129816 - Nirogi; Ramakrishna ; et al.	2012-05-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.